South Africa’s Competition Commission has referred pharmaceutical manufacturer Adcock Ingram’s hospital division to the Competition Tribunal for prosecution over alleged excessive pricing of kidney dialysis products. The referral, announced on 3 June 2026, targets Adcock Ingram Critical Care (AICC) and covers pricing for peritoneal dialysis and continuous renal replacement therapy (CRRT) products between July 2019 and June 2024. The commission…
Excessive Dialysis Product Pricing: Adcock Ingram Referred
Adcock Ingram Adcock Ingram Critical Care Bidvest Chronic Kidney Disease Competition Act Competition Commission Competition Tribunal Continuous Renal Replacement Therapy Dialysis Product Excessive Pricing Excessive Pricing healthcare costs Medical Schemes Natco Pharma Peritoneal Dialysis Renal Replacement Therapy South Africa